The AAD is working to expand the number and type of dermatology-specific measures available to dermatologists. Dermatology measures are needed to meet the reporting requirements for Centers for Medicare and Medicaid Services' (CMS) Physician Quality Reporting System (PQRS), which has transitioned to the Quality Payment Program in 2017. Measures are also needed for quality improvement efforts, particularly for the AAD’s dermatology clinical database registry DataDermTM.
Measure development process
AAD measure development is led by the physicians on the Performance Measurement Task Force (PMTF). The PMTF employs an evidence-based methodology to support measures with clinical practice guidelines, appropriate use criteria, and other evidence, such as data showing gaps in clinical care or the overuse of medical procedures or therapies. To determine priorities, the PMTF periodically conducts a needs assessment and then develops measures with staff support. Measures then undergo peer review by AAD committees, councils, and finally, the Board of Directors.
After approval, the measures are pilot tested with dermatology practices to determine validity, reliability, and feasibility. Measures are refined based on the results of testing and published.